MY120318A - Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses. - Google Patents

Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.

Info

Publication number
MY120318A
MY120318A MYPI98001431A MYPI9801431A MY120318A MY 120318 A MY120318 A MY 120318A MY PI98001431 A MYPI98001431 A MY PI98001431A MY PI9801431 A MYPI9801431 A MY PI9801431A MY 120318 A MY120318 A MY 120318A
Authority
MY
Malaysia
Prior art keywords
mixture
fatty acids
molecular weight
high molecular
sugar cane
Prior art date
Application number
MYPI98001431A
Other languages
English (en)
Inventor
Luis Gonzales Bravo
David Marrero Delange
Abilio Laguna Granja
Rosa Maria Mas Ferreiro
Maria De Lourdes Arruzazabala Valmana
Daysi Carbajal Quintana
Mirian Odette Cora Medina
Roberto Menendez Soto Del Valle
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of MY120318A publication Critical patent/MY120318A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
MYPI98001431A 1997-04-02 1998-04-01 Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses. MY120318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Publications (1)

Publication Number Publication Date
MY120318A true MY120318A (en) 2005-10-31

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98001431A MY120318A (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.

Country Status (19)

Country Link
US (1) US6486205B2 (enExample)
EP (1) EP0969827B1 (enExample)
JP (2) JP4907750B2 (enExample)
CN (1) CN1230158C (enExample)
AR (1) AR016054A1 (enExample)
AT (1) ATE233087T1 (enExample)
AU (1) AU732045B2 (enExample)
BR (1) BR9808470A (enExample)
CA (1) CA2285242C (enExample)
CO (1) CO4940484A1 (enExample)
CU (1) CU22723A1 (enExample)
DE (1) DE69811643T2 (enExample)
DK (1) DK0969827T3 (enExample)
ES (1) ES2192769T3 (enExample)
MY (1) MY120318A (enExample)
PT (1) PT969827E (enExample)
RU (1) RU2217130C2 (enExample)
WO (1) WO1998043631A1 (enExample)
ZA (1) ZA982744B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
PT1515714E (pt) * 2002-06-17 2009-10-06 Medestea Res & Production S P Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第１級脂肪族高級アルコ−ルの抽出法
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
AU732045B2 (en) 2001-04-12
RU2217130C2 (ru) 2003-11-27
JP2012067119A (ja) 2012-04-05
EP0969827A1 (en) 2000-01-12
WO1998043631A1 (en) 1998-10-08
CN1258218A (zh) 2000-06-28
PT969827E (pt) 2003-07-31
BR9808470A (pt) 2000-05-23
ES2192769T3 (es) 2003-10-16
CU22723A1 (es) 2002-02-28
US20020058705A1 (en) 2002-05-16
CA2285242C (en) 2008-12-16
CO4940484A1 (es) 2000-07-24
HK1029054A1 (en) 2001-03-23
ATE233087T1 (de) 2003-03-15
ZA982744B (en) 1998-10-08
JP2001518092A (ja) 2001-10-09
CA2285242A1 (en) 1998-10-08
DE69811643D1 (de) 2003-04-03
CN1230158C (zh) 2005-12-07
DE69811643T2 (de) 2003-12-24
AU7349498A (en) 1998-10-22
JP4907750B2 (ja) 2012-04-04
EP0969827B1 (en) 2003-02-26
US6486205B2 (en) 2002-11-26
DK0969827T3 (da) 2003-06-16
AR016054A1 (es) 2001-06-20

Similar Documents

Publication Publication Date Title
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
NO20092860L (no) 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
EP1017382A4 (en) BIARYL ALKANIC ACIDS USED AS CELL ADHESION INHIBITORS
MY132073A (en) Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
HUP0103542A2 (hu) Opioid-receptor aktivitással rendelkező 4,4-biaril-piperidin származékok és a vegyületeket tartalmazó gyógyászati készítmények
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
KR960013371A (ko) 약학적 혼합물
EE04111B1 (et) Raku adhesiooni inhibiitorid, nende kasutamine janeid sisaldavad farmatseutilised kompositsioonid
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
LV12766A (lv) Composition of l-dopa esters
BG104719A (en) Glucocorticoid-selective anti-inflammatory agents
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
BG104698A (en) Glucocorticoid-selective anti-inflammatory agents
ATE241346T1 (de) Arzneimittel enthaltend monoaminooxidase-b-hemmer
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
WO1993010742A3 (en) Chemical compounds, their preparation and use
WO1996022305A3 (en) Modified peptides
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
IL124431A0 (en) Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
KR960034200A (ko) 항편두통성 인돌릴알킬-피리딘일 및 피리미딘일피페라진의 1,2,5-티아디아졸 유도체